explore -WSS

explore

author：leisure time 2025-10-01 18:44:56 - browse：56

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

hotspot

knowledge

WSS

Cuban government calls US nuclear submarine stop a 'provocative escalation'

France's anti

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Democratic lawmaker calls for 'well

knowledge

explore

focus

Medical leaders decry Supreme Court decision on affirmative action

Britney Spears to release memoir, 'The Woman In Me,' later this year

Medicare proposal to cover medical devices draws a mixed reaction

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Affirmative action in medical school literally saved lives

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

DIEP, the 'gold standard' of breast reconstruction, is under threat

Sickle cell gene therapy cures need to be accessible in Africa

Psychedelics group wrestles with new pharma identity

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

knowledge

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

In medicine, common shorthands can shortchange care

'The Exorcist' director William Friedkin dead at 87

Sickle cell gene therapy cures need to be accessible in Africa

'The Exorcist' director William Friedkin dead at 87

In medicine, common shorthands can shortchange care

Wikipedia

hotspot

knowledge

leisure time